latest updates
-
The single-use upstream bioprocessing technology market is projected to grow at a CAGR of 12% till 2035, claims Roots Analysis Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems. For more information, please click on the following link: https://www.rootsanalysis.com/reports/single-use-upstream-bioprocessing-technology-market.html [more]
-
-
The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, growing at an annualized rate of 27.54% during the period 2021-2030, claims Roots Analysis Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance. For additional details, please visit https://www.rootsanalysis.com/reports/soft-tissue-sarcoma-market.html [more]
-
-
With over 280 therapies under evaluation, the stem cell therapy market is estimated to be worth USD 8.5 Billion by 2030, claims Roots Analysis With multiple approved products, the field of stem cell therapies has gained substantial momentum over the last decade; several innovator companies are currently progressing their proprietary therapy candidates with cautious optimism. For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/global-stem-cell-therapy-market-focus-on-cardiovascular-and-metabolic-disorders-2019-2030/246.html [more]
-
-
The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html [more]
-
-
The synthetic lethality-based drugs and targets market is estimated to be worth USD 8 billion in 2030, predicts Roots Analysis Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit. For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/synthetic-lethality-based-drugs-and-targets-market-2019-2030-focus-on-dna-repair-including-parp-inhibitors-and-other-novel-cellular-pathways/267.html [more]
-
-
The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html [more]
-
-
The human factors engineering and usability testing services market for medical devices is projected to reach USD 1 Billion by 2030, claims Roots Analysis Human factors engineering and usability testing have now become an essential part of product design across almost all industries, offering developers the chance to optimize proprietary products in alignment to the preferences of consumers. For additional details, please visit https://www.rootsanalysis.com/reports/human-factors-engineering-and-usability-testing-services.html [more]
-
-
Human Microbiome-based Products Market is projected to be worth USD 4 Billion by 2030, growing at an annualized rate of over 40%, claims Roots Analysis Over the years, extensive R&D efforts have established the basis for a wide range of microbiome-based therapeutic and diagnostic products, which may cause a paradigm shift in the way healthcare is delivered in the foreseen future. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/human-microbiome-market/281.html [more]
-
-
The intranasal therapeutics and drug delivery systems market is projected to grow at a CAGR of 18%, claims Roots Analysis Upon realizing the potential of this route of administration, industry stakeholders have initiated several R&D efforts focused on exploiting the use of intranasal therapeutics as an effective modality for the treatment of various disorders. For additional details, please visit https://www.rootsanalysis.com/reports/intranasal-therapeutics-and-drug-delivery-systems.html [more]
-
-
In silico drug discovery services market is likely to be worth USD 124 million by 2030, growing at an annualized rate of 15.6%, claims Roots Analysis Owing to their cost and time saving potential, in silico tools are widely used in modern pharmacological research; several companies have developed novel tools, which are specifically designed to accelerate and augment the drug discovery process. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/in-silico-drug-discovery/298.html [more]
-
-
In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, growing at an annualized rate of ~9.8%, predicts Roots Analysis With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions. For additional details, please visit https://www.rootsanalysis.com/reports/view_document/in-vitro-adme-testing-services-market-2019-2030/239.html [more]
-
-
The gene-editing beyond CRISPR market is anticipated to grow at an annualized rate of 18%, claims Roots Analysis With the approval of HUMULIN®, the first genetically modified drug, scientific community has made significant progress in developing gene edited therapies based on programmable nucleases, such as ZFNs, TALENs, EMNs and CRISPR. For additional details, please visit https://www.rootsanalysis.com/reports/gene-editing-market.html [more]
-
-
The Fc fusion therapeutics market is anticipated to grow at an annualized rate of over 10%, claims Roots Analysis Since the approval of Enbrel® in 1998 for the treatment of rheumatoid arthritis, Fc fusion therapies have evolved into a prominent class of therapeutics; currently, several therapies are being developed for a variety of disease indications. For additional details, please visit https://www.rootsanalysis.com/reports/fc-fusion-therapeutics-market.html [more]
-
-
The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, predicts Roots Analysis Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery. For more information, please click on the following link: https://www.rootsanalysis.com/reports/view_document/fragment-based-drug-discovery/309.html [more]
-
-
The global autoinjectors market is projected to grow at an annualized rate of over 10%, till 2030 Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients For more information please click on the following link: https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html [more]
0 following
Copyright 2019 © P-tweets Refunds